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University, Malmö, Sweden: 7Department of Epidemiology and Social Medicine, University of Aarhus, Aarhus,
Denmark: 8Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark: 9Cancer Research UK,
Oxford, UK: 10Strangeways Research Laboratory, University of Cambridge, Cambridge, UK: 11National Institute of
Public Health and the Environment, Bilthoven, The Netherlands: 12Julius Center for Health Sciences and Primary
Care, University Medical Center, Utrecht, The Netherlands: 13German Institute of Human Nutrition, Potsdam-
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Abstract
Background: In addition to their possible direct biological effects, plasma carotenoids
can be used as biochemical markers of fruit and vegetable consumption for
identifying diet–disease associations in epidemiological studies. Few studies have
compared levels of these carotenoids between countries in Europe.
Objective: Our aim was to assess the variability of plasma carotenoid levels within the
cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC).
Methods: Plasma levels of six carotenoids – a-carotene, b-carotene, b-cryptoxanthin,
lycopene, lutein and zeaxanthin – were measured cross-sectionally in 3043 study
subjects from 16 regions in nine European countries. We investigated the relative
influence of gender, season, age, body mass index (BMI), alcohol intake and smoking
status on plasma levels of the carotenoids.
Results: Mean plasma level of the sum of the six carotenoids varied twofold between
regions (1.35mmol l21 for men in Malmö, Sweden vs. 2.79mmol l21 for men in
Ragusa/Naples, Italy; 1.61mmol l21 for women in The Netherlands vs. 3.52mmol l21
in Ragusa/Naples, Italy). Mean levels of individual carotenoids varied up to fourfold
(a-carotene: 0.06mmol l21 for men in Murcia, Spain vs. 0.25mmol l21 for vegetarian
men living in the UK). In multivariate regression analyses, region was the most
important predictor of total plasma carotenoid level (partial R 2 ¼ 27.3%), followed by
BMI (partial R 2 ¼ 5.2%), gender (partial R 2 ¼ 2.7%) and smoking status (partial
R 2 ¼ 2.8%). Females had higher total carotenoid levels than males across Europe.
Conclusions: Plasma levels of carotenoids vary substantially between 16 different
regions in Italy, Greece, Spain, France, Germany, the UK, Sweden, Denmark and The
Netherlands. Compared with region of residence, the other demographic and lifestyle
factors and laboratory measurements have limited predictive value for plasma
carotenoid levels in Europe.
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Carotenoids are natural pigments generally found in fruit
and vegetables. They can be synthesised by plants but not
by animals and humans, and plant foods are therefore the
primary source for humans1. Although carotenoids can be
used as biomarkers of specific nutrients and their
relationship to diseases2–4, they are also known antiox-
idants5,6. Thus they are of interest in a variety of human
diseases whose aetiology is thought to involve oxidative
damage, including cancer7,8. The data on the relationship
of blood levels of these carotenoids with human disease
are not conclusive because of different study designs and
methodologies, including different laboratory method-
ologies8–11. At least 40 different carotenoids are present in
food12 and more than 10 of them have been identified in
blood13–15. However, little is known about the population
levels of these compounds and, to our knowledge, only
one published study has compared serum carotenoid
levels between European regions16. Olmedilla et al.
reported significant differences in serum carotenoid levels
among five European countries: France, Ireland, Spain, the
UK (Northern Ireland) and The Netherlands16. That study
was well-controlled in terms of laboratory analyses, the
recruitment of volunteers and their baseline data;
however, the study was relatively small, with only 349
participants from the five countries, and did not assess
possible predictors of carotenoids in participating centres.
In the European Prospective Investigation into Cancer
and Nutrition (EPIC), blood samples were collected from
386 080 healthy subjects, which makes it one of the largest
biorepositories in the world. We report here results on
plasma levels of six carotenoids from a large cross-
sectional sub-sample within the EPIC cohort, including
3043 men and women from 16 geographical areas in nine
European countries. We also examine the influence of
region, gender, season, age, body mass index (BMI),
alcohol intake, smoking status and various laboratory
parameters on the plasma carotenoid levels.
Subjects and methods
EPIC is a multi-centre prospective cohort study investi-
gating the relationship between diet, nutritional and
metabolic characteristics, various lifestyle and environ-
mental factors, and the risk of cancer, cardiovascular
disease, diabetes and other chronic diseases17. Twenty-
three research centres in 10 European countries are
participating in the EPIC study, which is co-ordinated by
the International Agency for Research on Cancer (IARC) in
Lyon, France. Collection of data and blood samples started
in 1992 and follow-up is planned for at least 15 years. EPIC
is unique in that it combines the largest and most diverse
number of subjects with information on their diet and
lifestyle, reported via questionnaires, and blood samples
collected from most of them. Samples are stored in order
to compare exposures of interest between individuals who
develop cancer during follow-up and those who do not
develop these cancers. One of the important features is
that the blood samples were collected using the same
protocol and preserved at very low temperatures.
Study population
In this analysis, 16 geographical areas (regions) were
designated by grouping centres within the EPIC study:
France (Paris and surroundings), Florence (central Italy),
Varese/Turin (northern Italy), Ragusa/Naples (southern
Italy), northern Spain (San Sebastian, Pamplona, Oviedo),
Granada (southern Spain), Murcia (south-eastern Spain),
Cambridge (subjects living in Norfolk), Oxford centre
(vegetarians living throughout the UK), The Netherlands
(including subjects from Utrecht and Bilthoven), Athens in
Greece, Heidelberg (south-west Germany), Potsdam
(former East Germany), Malmö (southern Sweden),
Umeå (northern Sweden) and Denmark (including
subjects from Aarhus and Copenhagen). Sub-samples of
100 women and 100 men in each of these regions were
randomly selected from a representative calibration
sample of 7% of the EPIC cohort18, for whom a complete
set of 14 aliquots of serum, plasma, buffy coat and red
blood cells was stored at IARC, Lyon. The selection
followed a stratified sampling scheme with 50 subjects (25
men and 25 women) in each of four age strata (45–49,
50–54, 55–59 and 60–64 years of age at the time of blood
sampling). Among the vegetarians from the UK, 65 of the
100 men selected were vegans (eating no animal products)
and 35 were lacto-vegetarians (eating no meat or meat
products); 88 of the 99 women selected were vegans and
11 were lacto-vegetarians. Both groups were combined
and are designated in the text as UK vegetarians.
For France, where only women were included in the
EPIC study, only 100 subjects were selected. Excluding
France from the multivariate regression analyses for total
plasma carotene level did not change gender as a
predictor of carotenoid levels. There were differences in
age groups for participants in the Danish, Umeå and Greek
cohorts. In the Danish cohort, participants were 50 years
and older at recruitment, so equal numbers were selected
in the three highest age strata. In the Umeå cohort,
participants were recruited in the year of their 50th or 60th
birthday, and equal numbers of both ages were included
in this study. In Greece, there were fewer subjects in the
highest age category, compensated for by more in the
youngest age strata.
As far as possible, equal numbers of subjects were
selected for each season at which their blood sample was
collected. In total, 3089 subjects were selected for
participation in the study. Four subjects had missing
aliquots, and 42 subjects were excluded because of
laboratory and other technical reasons, including 23
subjects that were run in one batch with incorrect readings.
Thus, the current analyses include 3043 subjects: 1464 men
and 1579 women. In the regression analyses, we excluded
individualswithmissing smoking information, and the final
number of subjects available for these analyses was 3011.
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Blood collection
When study participants visited the local study centre for
completion of questionnaires and anthropometric
measurements, a 30-ml peripheral blood sample was
drawn in three 10-ml Safety Monovettes (Sarstedt,
Nümbrecht, Germany), with participants mostly non-
fasting. One of the three syringes did not contain
anticoagulant, whereas the other two contained 1 ml of
3.13% trisodium citrate as anticoagulant. Filled syringes
were kept at 5–108C, protected from light, and transferred
to a central laboratory for further processing and
aliquoting. After centrifugation at 1500 g for 20 min, blood
fractions (serum, plasma, buffy coat and red blood cells)
were aliquoted into heat-sealed 0.5-ml plastic straws, using
a semi-automatic machine (CBS-IMV Technologies, Paris,
France). Samples were initially frozen at 2808C in a
horizontal position in order to prevent concentration
gradients, and then transferred into liquid nitrogen
(21968C). The 28 aliquots obtained from each subject
were divided into two identical series of 14 straws. One
series was stored locally in the study centre, and the other
was shipped in dry ice or liquid nitrogen to the central
biorepository at IARC in Lyon, France. Several centres
centralised blood processing in one laboratory, and
samples were shipped overnight in cool packs (France,
Bilthoven) or at ambient temperature (UK vegetarians)
from theblood collection site to the site of bloodprocessing
and freezing. Carotenoids are little affected by short-term
storage and transport as whole blood19,20. In Denmark,
Umeå and Malmö, blood was collected using different but
comparable techniques because these centres joined EPIC
after theyhad already collected theblood samples. Samples
were stored in nitrogen vapour (approximately 21508C) in
Denmark and in freezers at 2808C in the Swedish centres.
Subjects gave informed consent at the time of data and
blood collection, in accordance with local and IARC ethical
committee requirements.
Laboratory analyses
Aliquots of citrated plasma were extracted from the central
biorepository and arranged in batches containing plasma
from one subject from each participating centre. Samples
were stored in liquid nitrogen (21968C). On the day of
analysis, aliquots were rapidly thawed at room tempera-
ture (the large area/volume ratio of the CBS straws ensures
a rapid temperature shift). Samples (200ml) were analysed
for carotenoids by reversed-phase high-performance
liquid chromatography (HPLC; HPLC-1100 system, Hew-
lett Packard) following a method based on that of
Steghens et al.21. Samples were extracted with 800ml of
hexane after mixing for 30 min, and mobile phases were
concentrated with 1 ml l21 of triethylamine.
Samples were analysed in groups of the same sex and
age category (45–49, 50–54, 55–59 or 60–64 years), in
randomised order for region of residence of subjects. One
aliquot from a standard quality control sample was
analysed every day and injected at the beginning, middle
and end of each series. Analytical columns for HPLC were
changed after approximately 1100 injections. In total, five
different sets of columns were used during the study.
Calibration curves were made once a week, and the
standard mixture for calibration was renewed once.
Chromatograms were integrated automatically by the
system (Chemstation version 6.4; Hewlett Packard, Les
Ullis, France) but individually controlled by three different
laboratory technicians. Peaks for carotenoids that were
under the detection limits were set to zero, while peaks
that could not be detected because of technical problems
were excluded. Results for six plasma carotenoids are
presented in this paper. Plasma concentrations in subjects
from Sweden (Malmö and Umeå) were multiplied by 0.83
in order to obtain dilution levels for these heparin plasma
samples comparable to the citrated plasma used in the
core EPIC cohorts. This dilution factor was based on the
hypothesis that, on average, the haematocrit was 0.45 and
that, after centrifugation of the blood with anticoagulant,
all citrate was in the plasma. Between-day coefficients of
variation in concentrations of average population levels
and over the entire period of analysis (11 months) were
less than 7.6% except for zeaxanthin (16.5%). No
significant between day drift was observed.
Statistical methods
Data were analysed using the SAS System for Windows,
Release 8.0 (SAS Institute, Cary NC, USA). Since the means
and the medians were very similar (r ¼ 0.94–0.99), the
means and standard deviations are presented for non-
transformed data for descriptive purposes. The two-sided
Wilcoxon rank-sum test for non-parametric data was used
for comparison of concentrations between sexes. The
variability in plasma carotenoid concentrations that could
be explained by the variables of region (16 regions),
gender, season, age at blood collection (in years), body
mass index (BMI; kg m22), alcohol intake (g day21),
smoking status (non-smoker, previous smoker, current
smoker), fasting status at the time of blood collection (less
than 8 h or 8 h and more since fasting), storage time since
blood sampling, column and lifetime of column, duration
of calibration standard mixture and laboratory technician
were investigated with multivariate regression analysis
using GLM procedures in SAS. The plasma carotenoid
levels were log-transformed. Partial R 2 is the sum of
squares of an independent variable given other indepen-
dent variables in the model divided by the residual sum of
squares of the model excluding that independent variable
and then multiplying by 100 to get a percentage22. The
direction of the association in the model is not calculated
by the partial R 2 results and is not of interest to us since
several variables, such as region and season, are not
ordered categories. R 2 for the model was calculated by
dividing the uncorrected total sum of squares by the
corrected total sum of squares of the model.
Plasma carotenoids in nine European countries 715
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Because of the difference in their age groups, we
excluded the Danish, Umeå and Greek regions from
secondary multivariate regression analyses to assess the
impact of the age variables in the model and found only a
slight increase of 0.2% prediction in the variability of total
carotenoid level. To assess any possible bias being
introduced by the use of heparin plasma samples in
Malmö and Umeå, we carried out secondary analyses and
excluded them from the regression model, but this
lowered the contribution of only the variable ‘region’ to
the total plasma carotenoids level while the other variables
did not change appreciably. The lower contribution of
region is expected, since both centres are in the most
northern part of Europe, and excluding them is expected
to reduce the variability in carotenoid levels explained by
region of residence.
Results
Some characteristics of the study subjects are presented in
Table 1. Mean BMI of the participants varied substantially
between regions. The highest values were in the regions of
Spain, and the lowest values were among UK vegetarians.
Mean sample storage time for regions also varied from 1.7
to 5.9 years. Alcohol intake was substantially higher among
men than among women in almost all regions (Table 1).
The mean of the sum of the six measured carotenoids
(a-carotene, b-carotene, b-cryptoxanthin, lycopene,
lutein and zeaxanthin) varied twofold between regions
in men and women (1.35mmol l21 for men in Malmö vs.
2.79mmol l21 for men in Ragusa/Naples; 1.61mmol l21 for
women in The Netherlands vs. 3.52mmol l21 in Ragusa/
Naples) (Table 2). Mean carotenoid levels by region
showed broader distributions; Italian regions, Athens and
UK vegetarians had the highest lycopene and lutein levels
while b- and a-carotenes were highest among UK
vegetarians and in Heidelberg, and b-cryptoxanthin levels
were higher in the Spanish regions. Figure 1 shows
lycopene levels among men and women as an example of
the variability of individual carotenoids between regions.
Mean concentration of individual carotenoids varied up to
fourfold (a-carotene: 0.06mmol l21 for men in Murcia vs.
0.25mmol l21 for vegetarian men living in the UK). b-
Cryptoxanthin also varied several-fold between regions
for both men and women (mean level for men:
0.11mmol l21 in Denmark vs. 0.42mmol l21 in Granada;
mean level for women: 0.20mmol l21 in Malmö vs.
0.53mmol l21 in Ragusa/Naples). Lycopene was quantitat-
ively the most important carotenoid, followed by
Table 1 Mean and standard deviation (SD) of body mass index (BMI; kg m22), age (years), alcohol intake (g day21) and
storage of plasma samples (years) for EPIC study subjects in 16 regions of Europe. European Prospective Investigation
into Cancer and Nutrition
BMI Age Alcohol intake Sample storage
Region Gender Mean SD Mean SD Mean SD Mean SD
Varese/Turin Male 26.0 2.8 53.8 5.8 26.8 22.6 3.3 1.1
Female 25.6 4.1 54.1 5.5 8.0 10.8 4.3 1.1
Florence Male 26.5 3.2 54.0 5.6 22.5 22.9 3.7 1.4
Female 25.8 4.2 54.1 5.5 9.1 12.9 4.1 1.3
Ragusa/Naples Male 27.4 3.6 53.7 5.8 12.9 14.2 4.3 0.9
Female 27.3 4.4 53.9 5.6 5.3 7.6 4.6 0.9
Athens Male 27.5 3.0 51.4 6.1 12.9 13.8 4.1 1.0
Female 26.7 4.0 51.8 6.3 3.6 5.4 4.5 0.8
Granada Male 29.3 3.5 54.9 5.7 13.8 17.6 5.0 1.1
Female 29.4 4.6 54.5 5.9 2.2 5.9 5.1 1.0
Murcia Male 28.4 3.4 54.5 5.8 28.2 25.0 4.7 0.9
Female 30.4 4.4 54.4 5.6 7.0 11.4 5.3 0.7
Northern Spain Male 29.0 3.4 54.4 5.7 32.5 35.0 5.1 0.8
Female 28.1 4.1 54.5 5.8 5.6 9.9 5.7 0.8
France Female 24.7 4.1 54.1 5.3 11.5 11.6 2.4 0.4
UK vegetarians Male 23.1 2.8 54.8 5.8 9.9 14.0 3.5 0.9
Female 22.5 3.4 55.0 5.8 3.9 6.0 4.0 1.0
Cambridge Male 25.6 2.8 54.2 5.9 13.2 16.8 2.8 1.0
Female 25.0 3.9 54.0 5.4 7.0 12.5 3.2 0.8
Potsdam Male 27.5 3.6 54.1 5.7 21.5 18.4 1.7 0.4
Female 25.6 3.7 54.1 5.9 8.3 9.3 2.5 0.4
Heidelberg Male 26.8 3.5 54.5 5.5 23.6 20.7 1.8 0.6
Female 26.0 5.0 54.4 5.3 12.2 13.8 2.3 0.7
The Netherlands Male 26.5 3.6 55.0 5.8 17.9 20.5 2.6 0.7
Female 26.1 3.9 54.6 5.7 6.9 14.4 3.3 0.7
Denmark Male 26.6 3.4 56.9 4.3 26.4 23.4 2.2 0.3
Female 25.8 4.8 56.9 4.2 12.5 11.8 2.8 0.3
Malmö Male 26.3 3.4 54.4 5.0 16.3 15.2 5.9 1.0
Female 25.4 4.5 54.2 5.6 8.2 9.2 5.0 1.3
Umeå Male 26.2 3.5 54.6 5.0 5.6 4.8 4.5 1.2
Female 25.5 3.7 54.6 5.0 2.3 2.6 5.0 1.2
WK Al-Delaimy et al.716
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b-carotene, while a-carotene and zeaxanthin levels were
lowest compared with the other carotenoids.
Women had significantly higher total carotenoid levels
in all regions than men (Table 2). Using the Wilcoxon
signed-ranks test, all of these differences reached statistical
significance except in northern Spain. For individual
plasma carotenoids, women had higher b-carotene,
a-carotene and b-cryptoxanthin than did men within
each region. For lycopene, men had higher levels than did
women in 10 regions, and women had higher levels in six
regions. The higher lycopene levels among men compared
with women reached statistical significance in Florence,
northern Spain and Umeå. For lutein and zeaxanthin,
women had higher levels than did men in most regions.
In multivariate regression analyses for total carotenoid
level, region was the most important significant predictor
(partial R 2 ¼ 27.3%, P , 0.0001) for carotenoid level after
adjustment for other covariates of gender, season, age at
blood collection, BMI, alcohol intake and smoking status.
The overall R 2 for the model was 0.35 (P , 0.0001). We
excluded from the final model the variables of fasting
status, storage time after blood sampling, column and
lifetime of column, duration of calibration standard
mixture and laboratory technician, because they were
mostly non-significant and did not contribute more than
0.2% variability to any of the individual carotenoids. BMI
was the second most important predictor (partial
R 2 ¼ 5.2%, P , 0.0001) followed by smoking status
(partial R 2 ¼ 2.8%, P , 0.0001), gender (partial
R 2 ¼ 2.7%, P , 0.0001), season (partial R 2 ¼ 0.3%,
P , 0.04) and alcohol intake (partial R 2 ¼ 0.2%,
P , 0.01). The age variable was non-significant in the
model. For individual carotenoids, the multivariate
regression analyses generally followed a similar pattern
to the total carotenoids where region was the most
important predictor (Table 3). However, there were
differences in the contribution of the predictors to the
variability of b-cryptoxanthin and lycopene, where season
was the second most important independent predictor
while BMI was not an important predictor. Age was the
second most important predictor for zeaxanthin.
Discussion
This is the first large cross-sectional study analysing plasma
carotenoid levels in several European populations, with all
of the analyses being carried out in a single laboratory
using standardised protocols for the analytical methods.
Considerable variations in plasma concentrations of six
carotenoids were found between 16 regions in nine
European countries. Region was the most important
predictor of plasma carotenoids in regression analyses.
Table 2 Mean and standard deviation (SD) of plasma carotenoid levels (mmol l21) in EPIC study subjects in 16 regions of Europe.
European Prospective Investigation into Cancer and Nutrition
a-Carotene b-Carotene
b-Crypto-
xanthin Lycopene Lutein Zeaxanthin Total
Region Gender n Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Varese/Turin Male 99 0.15 0.11 0.42 0.25 0.32 0.18 1.03 0.43 0.60 0.24 0.13 0.06 2.64 0.83
Female 99 0.23 0.21 0.62 0.36 0.48 0.33 0.90 0.37 0.68 0.35 0.13 0.06 3.04 1.10
Florence Male 97 0.12 0.10 0.39 0.21 0.26 0.23 1.01 0.37 0.56 0.21 0.11 0.06 2.44 0.75
Female 99 0.16 0.12 0.55 0.33 0.35 0.26 0.90 0.36 0.66 0.27 0.11 0.06 2.73 0.92
Ragusa/Naples Male 92 0.08 0.12 0.39 0.22 0.31 0.22 1.29 0.46 0.61 0.26 0.11 0.05 2.79 0.81
Female 100 0.19 0.19 0.67 0.36 0.53 0.39 1.32 0.46 0.70 0.28 0.11 0.04 3.52 1.08
Athens Male 95 0.08 0.07 0.40 0.21 0.33 0.22 0.90 0.38 0.51 0.21 0.11 0.04 2.31 0.71
Female 99 0.13 0.10 0.53 0.24 0.44 0.32 0.87 0.47 0.58 0.25 0.10 0.05 2.66 0.90
Granada Male 97 0.07 0.06 0.24 0.13 0.42 0.35 0.69 0.40 0.40 0.16 0.10 0.04 1.90 0.68
Female 100 0.11 0.09 0.36 0.19 0.48 0.38 0.69 0.33 0.39 0.17 0.10 0.04 2.13 0.80
Murcia Male 99 0.06 0.06 0.25 0.14 0.35 0.24 0.66 0.30 0.37 0.17 0.11 0.05 1.79 0.63
Female 98 0.11 0.07 0.38 0.19 0.52 0.35 0.74 0.35 0.42 0.18 0.11 0.05 2.28 0.74
Northern Spain Male 97 0.08 0.09 0.21 0.15 0.30 0.21 0.53 0.31 0.36 0.15 0.12 0.05 1.61 0.70
Female 100 0.10 0.08 0.28 0.14 0.47 0.29 0.43 0.29 0.35 0.14 0.11 0.04 1.74 0.63
UK vegetarians Male 99 0.25 0.25 0.53 0.47 0.19 0.16 0.98 0.45 0.38 0.17 0.09 0.05 2.42 1.02
Female 99 0.32 0.28 0.68 0.71 0.24 0.16 0.89 0.44 0.48 0.21 0.09 0.05 2.70 1.10
Cambridge Male 98 0.16 0.10 0.41 0.23 0.14 0.10 0.72 0.30 0.26 0.12 0.06 0.04 1.76 0.54
Female 99 0.24 0.15 0.53 0.27 0.21 0.12 0.77 0.38 0.30 0.11 0.07 0.03 2.11 0.73
Potsdam Male 98 0.11 0.07 0.37 0.23 0.17 0.12 0.60 0.30 0.27 0.13 0.07 0.03 1.58 0.52
Female 99 0.23 0.24 0.64 0.44 0.27 0.18 0.69 0.33 0.36 0.15 0.08 0.03 2.26 0.93
Heidelberg Male 99 0.17 0.18 0.48 0.62 0.16 0.10 0.62 0.31 0.29 0.12 0.08 0.04 1.79 0.94
Female 99 0.22 0.21 0.65 0.64 0.25 0.18 0.54 0.25 0.39 0.17 0.10 0.05 2.14 1.00
The Netherlands Male 97 0.08 0.06 0.29 0.20 0.17 0.14 0.54 0.33 0.28 0.12 0.07 0.03 1.42 0.59
Female 99 0.12 0.08 0.37 0.28 0.27 0.18 0.47 0.26 0.32 0.12 0.08 0.03 1.61 0.60
Denmark Male 99 0.15 0.19 0.31 0.26 0.11 0.10 0.58 0.34 0.28 0.13 0.05 0.03 1.47 0.73
Female 98 0.22 0.18 0.47 0.38 0.23 0.21 0.53 0.29 0.34 0.14 0.07 0.04 1.86 0.84
Malmö Male 99 0.11 0.11 0.30 0.29 0.13 0.09 0.46 0.24 0.28 0.13 0.06 0.03 1.35 0.61
Female 97 0.20 0.22 0.54 0.73 0.20 0.19 0.52 0.27 0.28 0.12 0.06 0.04 1.80 1.08
Umeå Male 99 0.15 0.11 0.37 0.23 0.14 0.10 0.56 0.37 0.27 0.11 0.05 0.02 1.53 0.59
Female 99 0.29 0.24 0.66 0.73 0.24 0.16 0.44 0.25 0.31 0.13 0.06 0.03 1.99 1.02
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We found higher concentrations of total carotenoids in
southern European regions than in northern Europe. UK
vegetarians had carotenoid levels close to those found in
southern European regions, confirming the finding that
vegetarians consume qualitatively and quantitatively more
fruit and vegetables and have higher blood carotenoid
levels than comparable non-vegetarians23. Levels of
individual carotenoids were also generally higher in the
southern regions, except for a- and b-carotenes, which
showed no clear north–south difference.
Serum carotenoids have also been assessed in five
European countries by Olmedilla et al.16, who similarly
reported wide variability between northern and southern
Europe. Spain had the highest b-cryptoxanthin levels,
while lutein and zeaxanthin were higher in south Europe
(France and Spain) than in the north (Northern Ireland and
the Republic of Ireland). Similar to our study, there was no
clear north–south trend for a- and b-carotenes.
Fruit and vegetables are the main dietary sources of
carotenoids for humans, but correlations between intake
Fig. 1 Box plots of plasma lycopene levels for men (a) and women (b) according to region as an example of the variability of individual
carotenoids among the 16 regions participating in EPIC (European Prospective Investigation into Cancer and Nutrition). Whiskers are
the range of values (excluding outliers), boxes are 25–75%, middle line is median. Mal – Malmö; N-Spa – northern Spain; Net – The
Netherlands; Umea – Umeå; Den – Denmark; Pot – Potsdam; Gra – Granada; Hei – Heidelberg; Mur – Murcia; Cam – Cambridge;
Gre – Greece; Oxf – UK vegetarians; Va-Tu – Varese/Turin; Flo – Florence; Ra-Na – Ragusa/Naples
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and plasma levels of carotenoids are variable and range
from 0.1 to 0.724. This variability may be attributed to the
bioavailability of carotenoids from fruits and vegetables,
which may vary with cooking and processing25–28. On the
other hand, the bioavailability of carotenoids that are not
bound to protein complexes, such as those in supplements
or food colorants, which are used increasingly in certain
countries, is high29. The inter-individual variability in
bioavailability and absorption of carotenoids is difficult to
assess in large epidemiological studies. It is assumed that
the difference in bioavailability and absorption is random,
and did not bias levels of carotenoids from the different
countries to one direction or the other.
Season is an important factor in relation to carotenoid
levels in blood, because dietary sources of these
carotenoids are likely to vary by season. Seasonal factors
such as light and heat may affect the carotenoid content of
specific fruits and vegetables. We attempted to stratify by
season in the selection of subjects, and we further adjusted
for seasonal variations in the regression analyses.
Although season was statistically significant in the
regression model for all carotenoids, it was a more
important predictor for lycopene and b-cryptoxanthin
compared with the other variables in the model. Seasonal
variations in some serum carotenoids have been observed
by some investigators30–33 but not by others34,35. The
influence of season on intake of fruits and vegetables has
decreased in industrialised countries because of the
availability of these products all year long. Nevertheless,
it is likely that seasonal fruits and vegetables that are the
main source of certain carotenoids (tomatoes for
lycopene, citrus fruits for b-cryptoxanthin) will have a
significant effect on blood levels. The season of collection
of a blood sample from study participants thus has to be
taken into consideration in studies assessing carotenoids
among different populations.
Women in our study had higher plasma levels of
carotenoids than men, except for lycopene. This is in
agreement with data reported earlier31,33. This was also
found in EURAMIC (EURopean study on Antioxidants,
Myocardial Infarction and Cancer of the breast), where
adipose tissue carotenoid levels were measured among
986 subjects36. The difference between the sexes may be
due to quantitative and qualitative (relative to energy
intake) differences in intake, absorption and metabolism.
Hormonal changes during the menstrual cycle have been
shown to affect carotenoid serum levels in women37. In
regression analyses, however, gender was not as
important as region or BMI and was weakly predictive
for plasma lycopene and zeaxanthin. BMI has been found
to be negatively associated with plasma and adipose tissue
carotenoid levels38–41. In our regression analyses it was an
important predictor for plasma carotenoid levels, second
only to region. It is not fully understood why this variable
could be related to levels of carotenoids, but one
possibility is that people with high BMI are less likely to
consume fruits and vegetables, the main sources of plasma
carotenoids. According to Shils et al.42, distribution of
carotenoids in adipose tissue reflects that in plasma and
there is no differential tissue distribution for individual
carotenoids other than lutein/zeaxanthin in the macula of
the eye and b-carotene in the pineal gland.
Smoking and alcohol intake are thought to influence
carotenoid levels in blood40,43–46. Smoking is negatively
related to carotenoid levels, with smoking cessation
increasing plasma levels of carotenoids47, while alcohol is
believed to increase serum carotenoid levels43,44. In our
analyses, however, both smoking and alcohol contributed
little to the variability in carotenoid levels, even though
there was variability in smoking habits and alcohol intake
across regions. Except for zeaxanthin, age was not an
important predictor in the regression analyses, which is
most probably due to the stratified selection of samples
based on age in order to enable comparison between
subjects from different countries. There was limited
variability in age among our subjects, as shown in
Table 1. Others33 have found age to be positively
correlated with all carotenoids, except for b-crypto-
xanthin, while several studies found age to be negatively
associated with lycopene40,48,49.
The use of a standard protocol for collection and storage
of blood samples in all regions except Denmark and
Table 3 Multiple regression analyses of predictors of log-transformed plasma carotenoid levels in Europe (n ¼ 3011)
a-Carotene b-Carotene b-Cryptoxanthin Lycopene Lutein Zeaxanthin
Variable DF
Partial
R 2 (%) P-value*
Partial
R 2 (%) P-value*
Partial
R 2 (%) P-value*
Partial
R 2 (%) P-value*
Partial
R 2 (%) P-value*
Partial
R 2 (%) P-value*
Region 15 9.8 ,0.0001 7.8 ,0.0001 23 ,0.0001 29 ,0.0001 37 ,0.0001 26 ,0.0001
BMI 1 3.5 ,0.0001 4.2 ,0.0001 1.8 ,0.0001 0.8 ,0.0001 2.7 ,0.0001 1.5 ,0.0001
Gender 1 3.4 ,0.0001 3.7 ,0.0001 2.8 ,0.0001 0.2 0.004 1.9 ,0.0001 0.3 ,0.003
Season 3 0.4 0.006 0.8 ,0.0001 4.1 ,0.0001 2.9 ,0.0001 0.8 ,0.0001 1.4 ,0.0001
Age 1 0.4 ,0.0008 0.2 0.02 NS 0.5 ,0.0003 1.1 ,0.0001 3.2 ,0.0001
Alcohol intake 1 0.3 ,0.003 0.6 ,0.0001 0.5 ,0.0003 NS 0.2 0.03 0.3 0.005
Smoking status 2 1.4 ,0.0001 1.8 ,0.0001 2.6 ,0.0001 NS 1.6 ,0.0001 0.9 ,0.0001
Model R 2 24 0.25 0.24 0.34 0.32 0.40 0.29
DF – degrees of freedom; BMI – body mass index; NS – not significant (P . 0.05).
* P-values of F-test on type III sum of squares estimate.
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Sweden minimised potential bias. From our analyses, it
seemed unlikely that the different storage temperatures
between the EPIC study regions affected carotenoid levels.
Although there was wide variability in storage time
between regions, this did not affect carotenoid levels.
Carotenoids have been estimated to be stable for at least
15 years at temperatures below 2708C50. Brown et al.51
found no significant changes in individual or total plasma
carotenoids over a 4-h post-prandial period. As plasma in
the two Swedish regions was prepared from heparinised
blood, we had to apply a dilution coefficient in order to
obtain comparable values. Our assumption of an average
haematocrit of 0.45, and the different type of anticoagulant
used, may have biased results52 for these two cohorts.
However, when we excluded both these centres from our
analyses the conclusions of the study did not change.
All analyses of carotenoids were carried out in the same
laboratory, and between-day coefficients of variation were
low. The use of biochemical measurements in large-scale
epidemiological samples is feasible only with techniques
that are relatively cheap and do not need extended time
periods for analyses. Variability in performanceof columns,
calibration standards and laboratory technicians are among
potential sources of bias. However, in our analyses, the
inclusion of these parameters in regression analyses
indicated that the magnitude of their effect on plasma
carotenoid levels was limited in comparison to the effect of
region, BMI, gender and the other variables. Differences
between columns in completeness of separation between
the peaks of lutein and zeaxanthin may explain the higher
between-day coefficient of variation for zeaxanthin.
In conclusion, in this study of 16 geographical regions in
Europe, region was the most important predictor of
plasma levels of six different carotenoids. The rationale of
the EPIC study is to take full advantage of the regional
variations in both diet and cancer risk. Indeed, there are
variations of up to two- or threefold between northern and
southern Europe in age-standardised incidence rates of
cancers of the colon, breast, ovary and pancreas (more
frequent in the North)53. Assuming that diet is indeed the
most important determinant of plasma carotenoid levels,
the results of this cross-sectional study show that dietary
habits also vary widely across different regions of Europe.
With this considerable heterogeneity in both diet and
cancer incidence rates, it should be possible to carry out
more powerful studies of relationships between diet,
markers of diet and cancer risk.
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